627 related articles for article (PubMed ID: 9765334)
1. Exogenous leukotriene B4 (LTB4) inhibits human neutrophil generation of LTB4 from endogenous arachidonic acid during opsonized zymosan phagocytosis.
Fiedler J; Wheelan P; Henson PM; Murphy RC
J Pharmacol Exp Ther; 1998 Oct; 287(1):150-6. PubMed ID: 9765334
[TBL] [Abstract][Full Text] [Related]
2. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan.
Williams JD; Lee TH; Lewis RA; Austen F
J Immunol; 1985 Apr; 134(4):2624-30. PubMed ID: 2982947
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of 5-lipoxygenase products by electrospray mass spectrometry: effect of ethanol on zymosan-stimulated production of 5-lipoxygenase products by human neutrophils.
Wheelan P; Murphy RC
Anal Biochem; 1997 Jan; 244(1):110-5. PubMed ID: 9025916
[TBL] [Abstract][Full Text] [Related]
4. Release of leukotriene B4 from human neutrophils and its relationship to degranulation induced by N-formyl-methionyl-leucyl-phenylalanine, serum-treated zymosan and the ionophore A23187.
Palmer RM; Salmon JA
Immunology; 1983 Sep; 50(1):65-73. PubMed ID: 6309653
[TBL] [Abstract][Full Text] [Related]
5. Perturbation of beta-glucan receptors on human neutrophils initiates phagocytosis and leukotriene B4 production.
Czop JK; Puglisi AV; Miorandi DZ; Austen KF
J Immunol; 1988 Nov; 141(9):3170-6. PubMed ID: 2844908
[TBL] [Abstract][Full Text] [Related]
6. Modulation of leukotriene release from human polymorphonuclear leucocytes by PMA and arachidonic acid.
Raulf M; König W
Immunology; 1988 May; 64(1):51-9. PubMed ID: 2838420
[TBL] [Abstract][Full Text] [Related]
7. The effect of lipoproteins on the release of some eicosanoids by stimulated human leukocytes. A possible role in atherogenesis.
Croft KD; Proudfoot J; Moulton C; Beilin LJ
Eicosanoids; 1991; 4(2):75-81. PubMed ID: 1654959
[TBL] [Abstract][Full Text] [Related]
8. Release of leukotrienes by human monocytes on stimulation of their phagocytic receptor for particulate activators.
Williams JD; Czop JK; Austen KF
J Immunol; 1984 Jun; 132(6):3034-40. PubMed ID: 6327815
[TBL] [Abstract][Full Text] [Related]
9. Colchicine inhibits ionophore-induced formation of leukotriene B4 by human neutrophils: the role of microtubules.
Reibman J; Haines KA; Rich AM; Cristello P; Giedd KN; Weissmann G
J Immunol; 1986 Feb; 136(3):1027-32. PubMed ID: 3001184
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cytoskeletal rearrangement by botulinum C2 toxin amplifies ligand-evoked lipid mediator generation in human neutrophils.
Grimminger F; Sibelius U; Aktories K; Suttorp N; Seeger W
Mol Pharmacol; 1991 Oct; 40(4):563-71. PubMed ID: 1656192
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
[TBL] [Abstract][Full Text] [Related]
12. Enhanced generation of leukotriene B4 by neutrophils stimulated by unopsonized zymosan and by calcium ionophore after exercise-induced asthma.
Arm JP; Horton CE; House F; Clark TJ; Spur BW; Lee TH
Am Rev Respir Dis; 1988 Jul; 138(1):47-53. PubMed ID: 2849339
[TBL] [Abstract][Full Text] [Related]
13. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils.
Lee TH; Mencia-Huerta JM; Shih C; Corey EJ; Lewis RA; Austen KF
J Clin Invest; 1984 Dec; 74(6):1922-33. PubMed ID: 6096400
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of human neutrophil and alveolar macrophage LTB4 production by N-acetylcysteine: role of hydrogen peroxide.
Dent G; Rabe KF; Magnussen H
Br J Pharmacol; 1997 Oct; 122(4):758-64. PubMed ID: 9375974
[TBL] [Abstract][Full Text] [Related]
15. Bacterial lipopolysaccharides prime human neutrophils for enhanced production of leukotriene B4.
Doerfler ME; Danner RL; Shelhamer JH; Parrillo JE
J Clin Invest; 1989 Mar; 83(3):970-7. PubMed ID: 2537852
[TBL] [Abstract][Full Text] [Related]
16. Receptor antagonism of leukotriene B4 myotropic activity by the 2,6 disubstituted pyridine analog U-75302: characterization on lung parenchyma strips.
Lawson CF; Wishka DG; Morris J; Fitzpatrick FA
J Lipid Mediat; 1989; 1(1):3-12. PubMed ID: 2562431
[TBL] [Abstract][Full Text] [Related]
17. An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells.
Razin E; Romeo LC; Krilis S; Liu FT; Lewis RA; Corey EJ; Austen KF
J Immunol; 1984 Aug; 133(2):938-45. PubMed ID: 6330206
[TBL] [Abstract][Full Text] [Related]
18. Effect of cations on leukotriene release: requirements for the metabolism of peptido-leukotrienes (leukotrienes C4, D4) by human polymorphonuclear granulocytes.
Raulf M; Stüning M; König W
Immunology; 1986 Jul; 58(3):479-87. PubMed ID: 3733148
[TBL] [Abstract][Full Text] [Related]
19. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
Tsai BS; Keith RH; Villani-Price D; Haack RA; Djuric SW
J Pharmacol Exp Ther; 1994 Mar; 268(3):1493-8. PubMed ID: 8138959
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of leukotriene B4 by activated human polymorphonuclear granulocytes.
Brom J; Schönfeld W; König W
Immunology; 1988 Jul; 64(3):509-18. PubMed ID: 2842254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
